SBC Medicals EBITDA 2023-2024 | SBC
SBC Medicals ebitda from 2023 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| SBC Medicals Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-2 |
| 2022 | $-1 |
| SBC Medicals Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-1 |
| 2024-03-31 | $-1 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-0 |
| 2023-06-30 | $-0 |
| 2023-03-31 | $-0 |
| 2022-12-31 | |
| 2022-09-30 | $-0 |
| 2022-06-30 | $-0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.707B | $0.000B |
| SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.018B | 11.91 |
| Cencora (COR) | United States | $46.162B | 17.64 |
| DiDi Global (DIDIY) | China | $23.816B | 0.00 |
| ICON (ICLR) | Ireland | $18.182B | 16.19 |
| Natera (NTRA) | United States | $15.356B | 0.00 |
| Avantor (AVTR) | United States | $15.184B | 22.76 |
| Revvity (RVTY) | United States | $14.929B | 26.14 |
| Viatris (VTRS) | United States | $13.870B | 4.23 |
| BioMerieux (BMXMF) | France | $12.753B | 0.00 |
| Solventum (SOLV) | United States | $12.515B | 0.00 |
| CochLear (CHEOY) | Australia | $12.315B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.932B | 27.98 |
| Charles River Laboratories (CRL) | United States | $9.343B | 17.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.376B | 0.00 |
| Doximity (DOCS) | United States | $7.863B | 49.82 |
| HealthEquity (HQY) | United States | $7.539B | 40.92 |
| Bausch + Lomb (BLCO) | Canada | $7.221B | 33.62 |
| PACS (PACS) | United States | $6.544B | 0.00 |
| Life Times (LTH) | United States | $4.665B | 30.88 |
| Organon (OGN) | United States | $4.653B | 4.69 |
| Sotera Health (SHC) | United States | $4.492B | 22.66 |
| Surgery Partners (SGRY) | United States | $3.655B | 40.49 |
| BrightSpring Health Services (BTSG) | United States | $2.958B | 63.89 |
| Concentras Parent (CON) | United States | $2.542B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.527B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.482B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.349B | 88.43 |
| GeneDx Holdings (WGS) | United States | $2.094B | 0.00 |
| Premier (PINC) | United States | $2.032B | 9.14 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.586B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.402B | 7.04 |
| Progyny (PGNY) | United States | $1.354B | 23.81 |
| Pediatrix Medical (MD) | United States | $1.306B | 12.78 |
| Establishment Labs Holdings (ESTA) | $1.269B | 0.00 | |
| CareDx (CDNA) | United States | $1.194B | 0.00 |
| Agilon Health (AGL) | United States | $1.111B | 0.00 |
| Embecta (EMBC) | United States | $0.822B | 5.48 |
| InnovAge Holding (INNV) | United States | $0.803B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| DocGo (DCGO) | United States | $0.371B | 13.96 |
| Enhabit (EHAB) | United States | $0.365B | 31.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.325B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| ModivCare (MODV) | United States | $0.230B | 7.32 |
| Beauty Health (SKIN) | United States | $0.206B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.184B | 0.00 |
| MultiPlan (MPLN) | United States | $0.148B | 0.00 |
| Nutex Health (NUTX) | United States | $0.114B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.53 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |